alcoholic%20liver%20disease
ALCOHOLIC LIVER DISEASE
Alcoholic liver disease diagnosis is suggested by an established history of habitual alcohol intake of sufficient length and intensity.
Toxic daily threshold of alcohol consumption is 40-80 g for males and 20-40 g for females for 10-12 years.
Signs of alcohol abuse and hepatic injury include malnutrition and muscle wasting, cutaneous telangiectasia, palmar erythema, finger clubbing, Dupuytren's contracture, peripheral neuropathy, parotid gland enlargement and signs of gynecomastia and hypogonadism may also be present.

Introduction

Patient may present with signs and symptoms related to portal hypertension:
  • Abdominal wall collaterals
  • Ascites
  • Splenomegaly
  • Venous hum
  • Hepatic encephalopathy

Signs and Symptoms

Signs of Alcohol Abuse and Hepatic Injury

  • Malnutrition and muscle wasting
  • Jaundice
  • Cutaneous telangiectasia
  • Palmar erythema
  • Finger clubbing
  • Dupuytren’s contracture
  • Rhinophyma
  • Spider angioma
  • Peripheral neuropathy
  • Parotid gland enlargement
  • Signs of gynecomastia and hypogonadism may also be present

Others

  • Patient may be asymptomatic
  • Hepatomegaly, which is the most common sign in patients with alcoholic liver disease (ALD)
  • Hepatic bruit
  • Alcohol withdrawal (eg tremors, tachycardia, agitation, delirium tremens)
  • Anorexia, weight loss
  • Systemic inflammatory response syndrome (SIRS) (≥2 of the following: Heart rate >100 beats/minute, respiratory rate >12 breaths/minute, temperature >38°C or <36°C, WBC count >12,000 or <4000 mm)
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Gastroenterology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, 31 Dec 2019
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
Pearl Toh, 13 Jan 2020
Obeticholic acid significantly improves fibrosis and disease activity in patients with nonalcoholic steatohepatitis (NASH), a chronic liver disease currently with no approved therapy, according to an interim analysis of the landmark REGENERATE* study.
Stephen Padilla, 6 days ago
The Lancet Commission on Hypertension Group has recently released a position statement that contains a list of recommendations for the improvement of accuracy standards for devices that measure blood pressure (BP).